Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration.
- Authors
- Schroeder, Jason P; Iller, Kimberly A; Hodge, Clyde W
- Year
- 2003
- Journal
- Alcoholism, clinical and experimental research
- PMID
- 14691378
- DOI
- 10.1097/01.ALC.0000098873.80433.BA
BACKGROUND: Neuropeptide Y (NPY) is the most abundant and widely distributed peptide in the mammalian central nervous system and increases feeding behavior at NPY Y1 or Y5 receptor subtypes. Recent pharmacological and mutant mouse data indicate that NPY activity at its receptors can influence ethanol self-administration, although the direction and strength of this influence are not clear. METHODS: Effects of the novel NPY Y5 receptor antagonist L-152,804 on the onset and maintenance of operant self-administration were examined in male C57BL/6J mice, which were trained to self-administer ethanol (10% v/v) versus water via the sucrose substitution method during 16 hr overnight sessions. After 4 months of baseline responding, mice were injected with L-152,804 (0, 10, 30, or 60 mg/kg, intraperitoneally) before operant sessions. Potential locomotor effects of L-152,804 and possible interaction with the sedative properties of ethanol also were examined. RESULTS: All three doses of L-152,804 significantly delayed the onset of ethanol-reinforced responding relative to vehicle injection. L-152,804 produced no effect on the total number of ethanol- or water-reinforced responses per 16 hr session. However, L-152,804 selectively modulated the temporal distribution of ethanol-reinforced responding depending on the dose (10 and 60 mg/kg) and time point measured in a manner consistent with blockade of ethanol reinforcement. Additional experiments determined that L-152,804 (10 or 60 mg/kg) did not alter spontaneous locomotor activity or influence the sedative effects of ethanol (4 g/kg). CONCLUSIONS: These results indicate that blockade NPY Y5 receptor activity modulates the onset and maintenance of ethanol self-administration. For this reason, NPY-Y5 receptor antagonists may be useful in medical management of alcohol abuse and alcoholism.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. | 2008 | 18828811 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Neuropeptide Y in Alcohol Addiction and Affective Disorders. | Thorsell A et al. | — | 2017 | → |
| Drug addiction: An affective-cognitive disorder in need of a cure. | Fattore L et al. | — | 2016 | → |
| Relaxin-3 receptor (Rxfp3) gene deletion reduces operant sucrose- but not alcohol-responding in mice. | Walker AW et al. | — | 2015 | → |
| Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders. | Vadnie CA et al. | — | 2014 | → |
| Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission. | Quarta D et al. | — | 2014 | → |
| Mood and memory-associated behaviors in neuropeptide Y5 knockout mice. | Ito M et al. | — | 2013 | → |
| Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment. | Gonçalves J et al. | — | 2012 | → |
| Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice. | Sørensen G et al. | — | 2012 | → |
| Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors. | Orrù A et al. | — | 2012 | → |
| Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. | Chen J et al. | — | 2010 | → |
| Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats. | Zhang H et al. | — | 2010 | → |
| Neuroscience of alcoholism: molecular and cellular mechanisms. | Moonat S et al. | — | 2010 | → |
| The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. | Sparta DR et al. | — | 2009 | → |
| The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity. | Walker MW et al. | — | 2009 | → |
| CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. | Rubio M et al. | — | 2008 | → |
| Neurobiology of addiction. An integrative review. | Goodman A | — | 2008 | → |
| Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. | Wetherill L et al. | — | 2008 | → |
| Functional gene expression differences between inbred alcohol-preferring and -non-preferring rats in five brain regions. | Kimpel MW et al. | — | 2007 | → |
| Increased consumption but not operant self-administration of ethanol in mice lacking the RIIbeta subunit of protein kinase A. | Ferraro FM et al. | — | 2006 | → |
| The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. | Hodge CW et al. | — | 2006 | → |
| An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. | Hu X et al. | — | 2005 | → |
| Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. | Woldbye DP et al. | — | 2005 | → |
| The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats. | Schroeder JP et al. | — | 2005 | → |
| A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. | Thiele TE et al. | — | 2004 | → |
| Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice. | Sparta DR et al. | — | 2004 | → |